Nitrogen-containing bisphosphonates inhibit cell cycle progression in human melanoma cells
2004

Bisphosphonates and Melanoma

publication Evidence: moderate

Author Information

Author(s): A-M Forsea, C Müller, C Riebeling, C E Orfanos, C C Geilen

Primary Institution: Charité University Medical Center Berlin

Hypothesis

Can nitrogen-containing bisphosphonates inhibit cell cycle progression and induce apoptosis in human melanoma cells?

Conclusion

Nitrogen-containing bisphosphonates inhibit melanoma cell proliferation and induce apoptosis in a dose- and time-dependent manner.

Supporting Evidence

  • Nitrogen-containing bisphosphonates were shown to inhibit proliferation in melanoma cells.
  • Pamidronate and zoledronate induced apoptosis in a dose-dependent manner.
  • Clodronate did not significantly affect melanoma cell viability.

Takeaway

This study shows that certain medications called bisphosphonates can help stop melanoma cells from growing and can make them die.

Methodology

The study compared the effects of pamidronate, zoledronate, and clodronate on melanoma cell lines using various assays to measure cell proliferation, apoptosis, and cell cycle progression.

Limitations

The study was conducted in vitro, and the effects observed may not directly translate to in vivo conditions.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6602052

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication